---
figid: PMC7466743__fonc-10-01422-g0005
figlink: pmc/articles/PMC7466743/figure/F5/
number: F5
caption: 'Targeting the CLL/MSC crosstalk using CXCR4/CXCL12 and BCR signaling inhibitors.
  Several therapeutic strategies have been proposed to inhibit CLL/MSC interactions.
  (a) blocking of CXCR4 using AMD3100 () or using a CXCR4 antibody (); (b) blocking
  CXCL12 using NOX-A12 (); (c) CXCR4/CXCL12 and BCR pathways are interconnected, another
  way to interfere is to target BCR pathway using different inhibitors: ibrutinib
  that inhibits BTK and downstream events such as MAPK, PI3K, or NF-κB activation
  () but also reduces VLA-4 activation induced by CXCL12 binding () and cell adhesion
  (). Acalabrutinib () that similarly acts on the migration, the homing and the mobilization
  of leukemic cells in the circulation. Idelalisib or duvelisib also reduced the ability
  of stromal cells to support CLL migration and adhesion (); (d) finally, targeting
  the over-expression of BCL2 partially induced by the microenvironment has also been
  proposed (, ). Figure created with BioRender.com.'
pmcid: PMC7466743
papertitle: 'Importance of Crosstalk Between Chronic Lymphocytic Leukemia Cells and
  the Stromal Microenvironment: Direct Contact, Soluble Factors, and Extracellular
  Vesicles.'
reftext: Nathan Dubois, et al. Front Oncol. 2020;10:1422.
pmc_ranked_result_index: '77603'
pathway_score: 0.9782215
filename: fonc-10-01422-g0005.jpg
figtitle: Targeting the CLL/MSC crosstalk using CXCR4/CXCL12 and BCR signaling inhibitors
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7466743__fonc-10-01422-g0005.html
  '@type': Dataset
  description: 'Targeting the CLL/MSC crosstalk using CXCR4/CXCL12 and BCR signaling
    inhibitors. Several therapeutic strategies have been proposed to inhibit CLL/MSC
    interactions. (a) blocking of CXCR4 using AMD3100 () or using a CXCR4 antibody
    (); (b) blocking CXCL12 using NOX-A12 (); (c) CXCR4/CXCL12 and BCR pathways are
    interconnected, another way to interfere is to target BCR pathway using different
    inhibitors: ibrutinib that inhibits BTK and downstream events such as MAPK, PI3K,
    or NF-κB activation () but also reduces VLA-4 activation induced by CXCL12 binding
    () and cell adhesion (). Acalabrutinib () that similarly acts on the migration,
    the homing and the mobilization of leukemic cells in the circulation. Idelalisib
    or duvelisib also reduced the ability of stromal cells to support CLL migration
    and adhesion (); (d) finally, targeting the over-expression of BCL2 partially
    induced by the microenvironment has also been proposed (, ). Figure created with
    BioRender.com.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MSC
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - CXCL12
  - BCR
  - CXCR4
  - SYK
  - LYN
  - BTK
  - BCL2L1
  - BCL2
  - HDAC2
  - HDAC3
  - HDAC9
  - HDAC4
  - HDAC6
  - SIRT2
  - SIRT4
  - HDAC8
  - HDAC11
  - HDAC1
  - HDAC5
  - SIRT5
  - SIRT3
  - SIRT1
  - SIRT7
  - SIRT6
  - HDAC7
  - HDAC10
  - ibrutinib
  - fostamatinib
  - acalabrutinib
genes:
- word: MSC
  symbol: MSC
  source: hgnc_symbol
  hgnc_symbol: MSC
  entrez: '9242'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: CXCL12
  symbol: CXCL12
  source: hgnc_symbol
  hgnc_symbol: CXCL12
  entrez: '6387'
- word: BCR
  symbol: BCR
  source: hgnc_symbol
  hgnc_symbol: BCR
  entrez: '613'
- word: CXCR4
  symbol: CXCR4
  source: hgnc_symbol
  hgnc_symbol: CXCR4
  entrez: '7852'
- word: SYK
  symbol: SYK
  source: hgnc_symbol
  hgnc_symbol: SYK
  entrez: '6850'
- word: LYN
  symbol: LYN
  source: hgnc_symbol
  hgnc_symbol: LYN
  entrez: '4067'
- word: ВТК
  symbol: BTK
  source: hgnc_symbol
  hgnc_symbol: BTK
  entrez: '695'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: BCL21
  symbol: BCL2L
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L1
  entrez: '598'
- word: BCL2
  symbol: BCL2
  source: hgnc_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC2
  entrez: '3066'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC3
  entrez: '8841'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC9
  entrez: '9734'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC4
  entrez: '9759'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC6
  entrez: '10013'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT2
  entrez: '22933'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT4
  entrez: '23409'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC8
  entrez: '55869'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC11
  entrez: '79885'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC1
  entrez: '3065'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC5
  entrez: '10014'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT5
  entrez: '23408'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT3
  entrez: '23410'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT1
  entrez: '23411'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT7
  entrez: '51547'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT6
  entrez: '51548'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC7
  entrez: '51564'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC10
  entrez: '83933'
chemicals:
- word: ibrutinib
  source: MESH
  identifier: C551803
- word: fostamatinib
  source: MESH
  identifier: C523665
- word: acalabrutinib
  source: ''
  identifier: ''
diseases: []
figid_alias: PMC7466743__F5
redirect_from: /figures/PMC7466743__F5
figtype: Figure
---
